WOBURN, Mass. , June 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering, Evolution & Design (SEED) conference, taking
WOBURN, Mass. , May 27, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that Oliver Peoples , Ph.D., President and Chief Executive Officer of Yield10, will give a corporate presentation at the LD Micro Virtual Invitational XI
Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass. , May 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three
WOBURN, Mass. , May 10, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that management will participate at the Benzinga Global Small Cap Conference on May 14, 2021 . President and Chief Executive Officer Oliver Peoples , Ph.D.
WOBURN, Mass. , May 04, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that the Company will report its first quarter 2021 financial results and provide a corporate update on Tuesday, May 11, 2021 .
WOBURN, Mass. , March 18, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it will be featured as a presenting company at the Benzinga Biotech Small Cap Conference to be held on March 24-25, 2021 in a virtual format.
Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass. , March 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three
WOBURN, Mass. , March 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, announces that Chief Executive Officer Oliver Peoples , PhD. will present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021
WOBURN, Mass. , March 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2020 financial results and provide a corporate update on Tuesday, March 16, 2021 .
WOBURN, Mass. , March 01, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it will be featured as a presenting company at the Bank of America 2021 Virtual Global Agriculture & Materials Conference being held on March 3-4, 2021 .
WOBURN, Mass. , Feb. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it has received proceeds of approximately $3.8 million from the exercise of 472,099 warrants exercised between January 1, 2021 and February 16, 2021 ,
WOBURN, Mass. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per
WOBURN, Mass. , Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced the pricing of its underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share.
WOBURN, Mass. , Jan. 29, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock. The public offering is subject to market conditions, and there can be no
WOBURN, Mass. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced successful field testing of prototype lines of the oilseed Camelina sativa that have been programed to produce PHA bioplastics directly in seed.
WOBURN, Mass. , Dec. 02, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that Meghna Malik , Ph.D., Senior Director, will present at the 4 th CRISPR AgBio Congress which is being held December 1-3, 2020 as a virtual event. Dr.
WOBURN, Mass. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three and nine months ended September 30, 2020 . "We are very pleased with our strong progress across multiple fronts in the third
WOBURN, Mass. and HARPENDEN, U.K. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has signed a collaboration agreement with UK -based Rothamsted Research to support Rothamsted’s Flagship Program to develop omega-3
WOBURN, Mass. , Nov. 05, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), an agricultural bioscience company, announced today that the Company will report its third quarter 2020 financial results and provide a corporate update on Thursday, November 12, 2020 .
WOBURN, Mass. , Oct. 28, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it has begun field testing to evaluate the emergence and agronomics of winter Camelina sativa varieties.
